AFM
IMA

Anson Funds Management’s ImageneBio Inc IMA Stock Holding History

Anson Funds Management’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-17,443
Closed -$412K – 182
2023
Q4 		$412K Buy
+17,443
New +$569K 0.05% 134

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Anson Funds Management's IMA Position: Q1 2024 in Review

Anson Funds Management sold out of ImageneBio Inc (IMA) in Q1 2024, closing a stake of 17,443 shares — an estimated $412K sold.

Anson Funds Management first reported a position in IMA in Q4 2023 and held it in 1 quarter. The position peaked at $412K in Q4 2023. 55 funds tracked by Wall St. Rank hold IMA as of Q1 2024.

  • Anson Funds Management reported no remaining ImageneBio Inc position as of Q1 2024 after selling out during the quarter.
  • Anson Funds Management sold 17,443 ImageneBio Inc shares in Q1 2024, an estimated $412K.
  • Anson Funds Management first reported a position in ImageneBio Inc in Q4 2023 and held it in 1 quarter.
  • Anson Funds Management's ImageneBio Inc position peaked at $412K in Q4 2023.
  • 55 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2024.

Based on Anson Funds Management's 13F filing for Q1 2024, filed 14 May 2024.